The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Tumors in Rubinstein‐Taybi syndrome
Abstract
The 14 tumors reported in Rubinstein‐Taybi syndrome since 1989, when added to the 22 previously reported, are beginning to show a pattern of neural and developmental tumors, especially of the head, which is malformed in the syndrome. Among the neoplasms were 12 of the nervous system: 2 each of oligodendroglioma, medulloblastoma, neuroblastoma, and benign meningioma, a pheochromocytoma, and 3 other benign tumors; 2 of nasopharyngeal rhabdomyo‐sarcoma; and 1 each of leiomyosarcoma, seminoma, and embryonal carcinoma. Among the other benign tumors were an odontoma, a choristoma, a dermoid cyst, and 2 pilomatrixomas. © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293
Self-citationBloom Syndrome: A Mendelian Prototype of Somatic Mutational Disease
German, J. (1993) · Medicine · doi:10.1097/00005792-199311000-00003 · Cited by 593
A performance status scale for head and neck cancer patients
List, M. A., Ritter-Sterr, C., & Lansky, S. B. (1990) · Cancer · doi:10.1002/1097-0142(19900801)66:3<604::aid-cncr2820660334>3.0.co;2-l · Cited by 529
Malignancy in Neurofibromatosis
S�rensen, S. A., Mulvihill, J. J., & Nielsen, A. (2015) · Familial Cancer · doi:10.1159/000412547 · Cited by 267
Rubinstein-Taybi syndrome in the Netherlands
Hennekam, R. C. M., van den Boogaard, M. H., Sibbles, B. J., & Spijker, H. G. V. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370604 · Cited by 117
Ruymann, F. B., Maddux, H. R., Ragab, A. H., Soule, E. H., Palmer, N., Beltangady, M. S., Gehan, E. A., & Newton, W. A. (1988) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950160109 · Cited by 91
Cohen, B. H. (1992) · Neurology · doi:10.1212/wnl.42.12.2308-c · Cited by 89
Keloids and neoplasms in the Rubinstein‐Taybi syndrome
Siraganian, P. A., Rubinstein, J. H., & Miller, R. W. (1989) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950170526 · Cited by 82
Self-citationDeletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects.
Hennekam, R. C. M., Tilanus, M. G. J., Hamel, B. C. J., Heeren, H. V.-V., Mariman, E. C. M., van Beersum, S. E. C., van den Boogaard, M. H., & Breuning, M. H. (1993) · Europe PMC (PubMed Central) · Cited by 68
Cited by
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
CBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
“As previously discussed, CPB and p300 have been proposed to be tumor suppressors and studies of RTS patients have suggested that these individuals may be at risk for developing certain types of cancer (Miller and Rubinstein 1995).”
BackgroundRubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
“Meanwhile, loss of another family member, p300, has also been associated with hematological malignancies.(179,180) Therefore, both CBP and p300 seem to function as tumor suppressors.”
BackgroundRosenfeld, M. G., Lunyak, V. V., & Glass, C. K. (2006) · Genes & Development · doi:10.1101/gad.1424806 · Cited by 952
Metadata
- Authors
- Miller, R. W., & Rubinstein, J. H.
- Venue
- American Journal of Medical Genetics
- Publisher
- Wiley
- Published
- 1995-03-13
- Volume
- 56
- Issue
- 1
- Pages
- 112-115
- ISSN
- 0148-7299 (ISSN-L)
- 1096-8628
- OpenAlex
- W2120412844
- Cited by
- 283
- References
- 9
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.